BI-RADS

1. BI-RADS By Nina Zahedi MD

2. Why BI-RADS?

4. Confusion

5. If I report she is really sick what happens if she is not? If I report normal what happens if she is really sick?

6. Consultation

7. And now Baby of 1997 !

8. Breast Imaging Reporting and Data System (BI-RADS). • Having a standard way of reporting mammogram results , meaning: • Lets doctors use the same words and terms for describing the findings , • Reduce confusion in breast imaging interpretations, • and Facilitate outcome monitoring.

9. Overall assessment & Recommendation studies Report organisation Indication Breast composition Findings Comparison to previous study

10. If more than one imaging modality is performed, an integrated report with assessment based on the highest level of suspicion must be used.

11. Mammographic Breast Composition The breast is almost entirely fat(<25% FGT) Scattered fibroglandular densities (25-50%) Heterogeneously dense breast tissue(51-75%) Extremely dense (> 75% glandular)

14. BIRADS Lexicon • Mass • Architectural distortion • Asymmetry • Calcification

15. BI-RADS 1 Negative: There is nothing to comment on. ( either abnormal or normal)

17. BI-RADS 2 :Benign Lesion

18. Benign Masses can be Ignored • a-Raised skin lesionsSeborrheickeratosis • b-Intramammary lymph nodes • c-Fat containing lesions(Encapsulated lucent lesions)Lipomas Fat necrosis forming oil cystsGalactoceles • c-Mixed-density lesionsHamartomas, Hematomas

19. d-Multiple rounded densities • e-Benign calcified masses Calcifying involutingfibroadenomas • f-Benign masses with peripheral calcifications Calcifying involutingfibroadenomas Cysts with calcified walls Fat necrosis • g-Calcifying large duct papillomas • h-Cysts with precipitated calcium

20. The verrucoid appearance is typical of the benign, cutaneousseborrheickeratosis that is projecting over the breast.

21. Typical appearance of a benign, intramammary lymph node.

22. Fatty-replaced intramammarynode. Single intramammarylymph node contains so much fat that it appears to be multiple masses .

24. Lipoma: The palpable mass in the axillary tail is radiolucent with a thin capsule .

25. Posttraumatic oil cyst: A palpable mass in an area of previous surgery. It represents encapsulated, radiolucent fat and is a form of benign fat necrosis . No need for further investigation.

26. Calcified oil cyst :This calcified mass represents an area of fat necrosis. The non calcified portion is relatively radiolucent.

27. These calcifications are in the wall of a cyst .This lesion requires no further evaluation.

28. Hamartoma: This mixed lesion contains fat and fibroglandular tissue. Requires no further evaluation.

30. Cysts accounting for multiple rounded densities

31. Multiple fibroadenomas can account for multiple rounded densities

32. Normal breast tissue may project as multiple rounded densities not cysts!

33. CALCIFICATIONS THAT CAN BE IGNORED • Lucent-centered calcificationsSkin calcificationsFat necrosisSecretory calcifications(Large rod-shaped calcifications) • Milk of calcium • Vascular calcifications • Dystrophic calcifications • Diffusely scattered calcifications (? bilateral) • Foreign Body Reaction and Calcified Suture Material • Artifacts and Skin Contaminants

34. Skin calcifications

35. Dystrophic and suture calcifications

36. Diffusely scattered calcifications

37. BI-RADS 3 • Probably Benign Finding - Initial Short-Interval Follow-Up Suggested: A finding placed in this category should have less than a 2% risk of malignancy. It is not expected to change over the follow-up interval, but the radiologist would prefer to establish its stability.

38. Solitary circumscribed mass • Solitary asymmetric duct • Round, regular clustered calcifications

40. Non-palpable sharply defined lesion with a cluster of punctate calcification

41. The initial short-term follow-up : • A unilateral mammogram at 6 months, • Then a bilateral follow-up examination at 12 months and 24 months after the initial examination. If the findings shows no change in the follow up the final assessment is changed to BI-RADS 2 (benign) and no further follow up is needed.

42. Follow up at 6, 12 and 24 months showed no change. Final assessment was changed to a Category 2.

43. If a BI-RADS 3 lesion shows any change during follow up, • It will change into a BI-RADS 4 or 5 and appropriate action should be taken.

44. Category 3 lesion:There are two indeterminate or amorphous calcifications.

45. Final diagnosis:Invasive carcinoma within an area of DCIS.

46. First control after conservative treatment for breast cancer: • New scars and post irradiation thickening of skin and interestitiumis assigned BI-RADS 3. • second control after Conservative treatment for breast cancer: decrease of sequelaeof treatment, BI-RADS category can be changed into BI-RADS 2.

47. First and second control after conservative treatment for breast cancer (BI-RADS 3 and 2)

48. BI-RADS 4 Suspicious Abnormality - Biopsy Should Be Considered:BI-RADS 4 is reserved for findings that do not have the classic appearance of malignancy but have a wide range of probability of malignancy (2 - 95%). 

49. Lesions with Ill-Defined Margins. • Lesions with a Microlobulated Margin. • Architectural Distortion. • Distorted Parenchymal Edge. • Density Increasing Over Time. • Focal Asymmetric Density. • Clustered Microcalcifications.

50. Category 4: There is an abnormality suspicious for malignancy, but a benign lesion.